Journal of
Cell Biology and Genetics

  • Abbreviation: J. Cell Biol. Genet.
  • Language: English
  • ISSN: 2141-6516
  • DOI: 10.5897/JCBG
  • Start Year: 2010
  • Published Articles: 14

Full Length Research Paper

Pancreatic response after treatment with 1,5-Bis(3,5- dimethylpyrazol-1-yl)-3-oxapentane diacetatocopper in rats

Nofa, A.E.*
  • Nofa, A.E.*
  • Department of Zoology, Faculty of Science, Menoufia University, Egypt.
  • Google Scholar
Lampatov, V.V.
  • Lampatov, V.V.
  • Department of Pharmacology, Altai State Medical University, Barnaul, Russia.
  • Google Scholar
Lepilov, A.V.
  • Lepilov, A.V.
  • Department of Pathological Anatomy, Altai State Medical University, Barnaul, Russia.
  • Google Scholar

  •  Received: 18 January 2014
  •  Accepted: 12 June 2015
  •  Published: 30 June 2015


3,5-Dimethylpyrazole (U-6245) is a hypoglycemic and antilipolytic agent used in the treatment of diabetes mellitus. Complex 1,5-Bis(3,5-dimethylpyrazol-1-yl)-3-oxapentane diacetatocopper was prepared in 2009. This study indicated that 1,5-Bis(3,5-dimethylpyrazol-1-yl)-3- oxapentane-diacetatocopper has hypoglycemic properties by decreasing glucose level in blood but caused histopathological changes in the pancreas rats. Rats treated with 1,5-Bis(3,5-dimethylpyrazol-1- yl)-3-oxapentane diacetatocopper for 2, 4 and 6 weeks revealed inflammatory infiltration in the pancreas, marked cytoplasmic vacuoles, congestion of blood vessels with edema and haemorrhage, as well as, some of the degenerated cells showed necrosis. Large spaces were detected in some areas due to degeneration of cells. Sera of animals treated with 1,5-Bis(3,5-dimethylpyrazol-1-yl)-3-oxapentane diacetatocopper in the present study revealed a significant decrease in serum glucose after 2, 4 and 6 weeks of treatment.

Key words: Hypoglycemic agent, glucose, pancreas, necrosis.